Titan Pharmaceuticals: Funding, Investors & Team (Oct 2026)
Titan Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing innovative treatments for serious medical conditions. Its main product, Probuphine®, is a slow-release implant of buprenorphine hydrochloride designed to provide continuous medication for up to six months. This implant aims to improve patient compliance and reduce the risk of illicit use or accidental exposure compared to traditional oral formulations of buprenorphine. Titan has submitted a New Drug Application (NDA) to the FDA for approval to treat opioid dependence and has entered into a partnership with Braeburn Pharmaceuticals for commercialization in the U.S. and Canada. In addition, Titan is exploring the potential application of its ProNeura™ drug delivery technology for other chronic conditions, such as Parkinson's disease. The company also benefits from royalty revenue from the sale of Fanapt®, an atypical antipsychotic, through a licensing agreement with Novartis Pharma AG.
Titan Pharmaceuticals has raised $1.0M across 1 funding round on record, the most recent an undisclosed round of $1.0M announced in Apr 2025.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Titan Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Apr 2025.
Titan Pharmaceuticals Funding Rounds
Titan Pharmaceuticals Founders and Leadership Team
Contact details for the Titan Pharmaceuticals team: 1 of 1 has an email address on file.
Start 14-day free trial →Titan Pharmaceuticals Funding Compared to Other Biotechnology Startups
Titan Pharmaceuticals' latest round of $1.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Titan Pharmaceuticals in Biotechnology and South San Francisco
Companies Similar to Titan Pharmaceuticals
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Titan Pharmaceuticals Funding FAQs
What does Titan Pharmaceuticals do?
Titan Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing innovative treatments for serious medical conditions. Its main product, Probuphine®, is a slow-release implant of buprenorphine hydrochloride designed to provide continuous medication for up to six months. This implant aims to improve patient compliance and reduce the risk of illicit use or accidental exposure compared to traditional oral formulations of buprenorphine. Titan has submitted a New Drug Application (NDA) to the FDA for approval to treat opioid dependence and has entered into a partnership with Braeburn Pharmaceuticals for commercialization in the U.S. and Canada. In addition, Titan is exploring the potential application of its ProNeura™ drug delivery technology for other chronic conditions, such as Parkinson's disease. The company also benefits from royalty revenue from the sale of Fanapt®, an atypical antipsychotic, through a licensing agreement with Novartis Pharma AG.
How much funding has Titan Pharmaceuticals raised?
Titan Pharmaceuticals has raised $1.0M across 1 round on record. The most recent is an undisclosed round of $1.0M announced in Apr 2025.
When did Titan Pharmaceuticals last raise funding?
Titan Pharmaceuticals' most recent funding round on record is an undisclosed round of $1.0M, announced in Apr 2025.
Who founded Titan Pharmaceuticals?
FundedIQ lists Sunil Bhonsle (Founder) at Titan Pharmaceuticals.
Where is Titan Pharmaceuticals headquartered?
Titan Pharmaceuticals is based in South San Francisco, California, United States.
How many employees does Titan Pharmaceuticals have?
Titan Pharmaceuticals is in the 11-50 employee band.
How does Titan Pharmaceuticals' funding compare to other Biotechnology startups?
Titan Pharmaceuticals' latest round of $1.0M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Titan Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Titan Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.